Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis
177Lu HTK03170 - BC Cancer Agency
https://psmaconference.ucsf.edu/poster-abstracts
 
Sara Kurkowska
 
Mar 26, 2025
 
Prev Next